11月6日，华康洁净涨0.40%，成交额5520.64万元。两融数据显示，当日华康洁净获融资买入额654.31 万元，融资偿还908.56万元，融资净买入-254.25万元。截至11月6日，华康洁净融资融券余额合计 9875.20万元。 融资方面，华康洁净当日融资买入654.31万元。当前融资余额9875.20万元，占流通市值的3.05%，融资 余额超过近一年90%分位水平，处于高位。 融券方面，华康洁净11月6日融券偿还0.00股，融券卖出0.00股，按当日收盘价计算，卖出金额0.00元； 融券余量0.00股，融券余额0.00元，超过近一年80%分位水平，处于高位。 资料显示，武汉华康世纪洁净科技股份有限公司位于湖北省武汉市东湖新技术开发区高新大道718号3 栋，成立日期2008年11月12日，上市日期2022年1月28日，公司主营业务涉及医疗净化系统研发、设 计、实施和运维,相关医疗设备和医疗耗材的销售。主营业务收入构成为：净化系统集成85.24%，医疗 耗材销售8.53%，医疗设备销售3.74%，运维服务1.88%，其他(补充)0.61%。 截至10月31日，华康洁净股东户数1.06万，较上期增加2.4 ...

Core Viewpoint - Huakang Clean experienced a stock price decline of 2.16% on November 4, with a current price of 29.96 CNY per share and a market capitalization of 3.229 billion CNY [1] Financial Performance - For the period from January to September 2025, Huakang Clean achieved a revenue of 1.431 billion CNY, representing a year-on-year growth of 32.59% [2] - The net profit attributable to the parent company was 61.1567 million CNY, showing a significant year-on-year increase of 211.46% [2] Shareholder Information - As of October 20, 2025, the number of Huakang Clean's shareholders decreased by 1.61% to 10,400, while the average circulating shares per person increased by 1.64% to 7,011 shares [2] - The company has cumulatively distributed dividends of 40.0214 million CNY since its A-share listing, with 29.4614 million CNY distributed over the past three years [3] Stock Market Activity - Huakang Clean's stock has seen a year-to-date increase of 48.60%, but has declined by 3.48% over the last five trading days and 10.73% over the last 20 days [1] - The company has appeared on the "Dragon and Tiger List" twice this year, with the most recent appearance on July 31 [1] Business Overview - Huakang Clean, established on November 12, 2008, and listed on January 28, 2022, specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1] - The revenue composition of Huakang Clean includes 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, 1.88% from operation and maintenance services, and 0.61% from other sources [1] - The company operates within the pharmaceutical and biological industry, specifically in the medical device sector, and is involved in concepts such as medical waste treatment, assisted reproduction, medical devices, smart healthcare, and artificial intelligence [1]

Group 1 - The core viewpoint of the news is that Huakang Clean experienced a decline in stock price, dropping by 5.09% to 31.15 CNY per share, with a trading volume of 160 million CNY and a turnover rate of 6.99%, resulting in a total market capitalization of 3.357 billion CNY [1] - Huakang Clean, established on November 12, 2008, and listed on January 28, 2022, specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1] - The revenue composition of Huakang Clean includes: 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, 1.88% from operation and maintenance services, and 0.61% from other sources [1] Group 2 - Among the top ten circulating shareholders of Huakang Clean, a fund under China Merchants Fund, specifically the China Merchants Quantitative Selected Stock A (001917), has newly entered the list in the third quarter, holding 470,000 shares, which accounts for 0.65% of the circulating shares [2] - The estimated floating loss for the fund today is approximately 784,800 CNY [2] - The China Merchants Quantitative Selected Stock A fund, established on March 15, 2016, has a latest scale of 3.663 billion CNY, with a year-to-date return of 43.95%, ranking 1030 out of 4218 in its category, and a one-year return of 48.62%, ranking 670 out of 3878 [2]

Group 1 - The core point of the news is that Huakang Clean experienced a decline of 5.42% in its stock price, reaching 33.70 CNY per share, with a trading volume of 53.69 million CNY and a turnover rate of 2.15%, resulting in a total market capitalization of 3.63 billion CNY [1] - Huakang Clean, established on November 12, 2008, and listed on January 28, 2022, is based in Wuhan, Hubei Province, and specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1] - The revenue composition of Huakang Clean includes: 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, 1.88% from operation and maintenance services, and 0.61% from other supplementary services [1] Group 2 - Among the top ten circulating shareholders of Huakang Clean, a fund under China Merchants Fund, specifically the China Merchants Quantitative Selected Stock A (001917), has newly entered the list in the third quarter, holding 470,000 shares, which accounts for 0.65% of the circulating shares [2] - The China Merchants Quantitative Selected Stock A fund, established on March 15, 2016, has a latest scale of 2.765 billion CNY, with a year-to-date return of 42.35% and a one-year return of 49.25%, ranking 1008 out of 4218 and 673 out of 3876 respectively [2] - The fund manager, Wang Ping, has a cumulative tenure of 15 years and 132 days, with the fund's total asset scale at 16.687 billion CNY, achieving a best return of 282.09% and a worst return of -70.61% during his tenure [2]

Core Viewpoint - Huakang Clean experienced a stock price decline of 2.01% on October 22, with a current price of 34.04 CNY per share and a total market capitalization of 3.668 billion CNY [1] Group 1: Stock Performance - Year-to-date, Huakang Clean's stock price has increased by 68.84%, with a recent decline of 1.36% over the last five trading days [1] - The stock has appeared on the "Dragon and Tiger List" twice this year, with the most recent occurrence on July 31 [1] Group 2: Financial Performance - For the first half of 2025, Huakang Clean reported a revenue of 833 million CNY, representing a year-on-year growth of 50.73%, and a net profit of 18.683 million CNY, up 273.48% year-on-year [2] - Cumulative cash dividends since the company's A-share listing amount to 40.0214 million CNY, with 29.4614 million CNY distributed over the past three years [3] Group 3: Shareholder Information - As of October 10, 2023, Huakang Clean had 10,500 shareholders, a decrease of 1.58% from the previous period, with an average of 6,898 circulating shares per shareholder, an increase of 1.60% [2] - Notable new institutional shareholders include Anxin Medical Health Stock A, holding 652,800 shares, and Nuoan Multi-Strategy Mixed A, holding 429,900 shares [3] Group 4: Business Overview - Huakang Clean, established on November 12, 2008, and listed on January 28, 2022, specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1] - The company's revenue composition includes 85.24% from purification system integration, 8.53% from medical consumables, 3.74% from medical equipment sales, 1.88% from operation services, and 0.61% from other sources [1]

Core Viewpoint - The stock of Huakang Clean has experienced fluctuations, with a year-to-date increase of 65.57% but a recent decline in the last five trading days by 2.40% [1] Financial Performance - For the first half of 2025, Huakang Clean achieved a revenue of 835 million yuan, representing a year-on-year growth of 50.73%, and a net profit attributable to shareholders of 18.68 million yuan, up 273.48% year-on-year [2] - The company has distributed a total of 40.02 million yuan in dividends since its A-share listing, with 29.46 million yuan distributed over the past three years [3] Stock Market Activity - As of October 20, Huakang Clean's stock price was 33.38 yuan per share, with a market capitalization of 3.597 billion yuan [1] - The stock has seen significant trading activity, with a turnover of 92.99 million yuan and a turnover rate of 3.77% on the same day [1] - The company has appeared on the "Dragon and Tiger List" twice this year, with the most recent occurrence on July 31 [1] Shareholder Information - As of October 10, the number of shareholders for Huakang Clean was 10,500, a decrease of 1.58% from the previous period, while the average number of circulating shares per person increased by 1.60% to 6,898 shares [2] - Notable new institutional shareholders include Anxin Medical Health Stock A and Nuoan Multi-Strategy Mixed A, holding 652,800 shares and 429,900 shares respectively [3] Business Overview - Huakang Clean, established on November 12, 2008, and listed on January 28, 2022, specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1] - The revenue composition of the company includes 85.24% from purification system integration, 8.53% from medical consumables, 3.74% from medical equipment sales, 1.88% from operation services, and 0.61% from other sources [1]

Core Insights - Huakang Clean's stock price increased by 5.3% to 34.96 CNY per share, with a trading volume of 95.89 million CNY and a turnover rate of 3.91%, resulting in a total market capitalization of 3.768 billion CNY [1] Company Overview - Wuhan Huakang Century Clean Technology Co., Ltd. is located in the East Lake New Technology Development Zone, Wuhan, Hubei Province, and was established on November 12, 2008, with its listing date on January 28, 2022 [1] - The company's main business involves the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1] - Revenue composition: Purification system integration accounts for 85.24%, medical consumables sales 8.53%, medical equipment sales 3.74%, operation and maintenance services 1.88%, and other supplementary services 0.61% [1] Shareholder Insights - Anxin Fund has a presence among Huakang Clean's top ten circulating shareholders, with Anxin Medical Health Stock A (010709) newly entering the top ten in the second quarter, holding 652,800 shares, which is 1.28% of the circulating shares [2] - The estimated floating profit for Anxin Medical Health Stock A today is approximately 1.1489 million CNY [2] - Anxin Medical Health Stock A was established on January 12, 2021, with a latest scale of 442 million CNY, achieving a year-to-date return of 64.37%, ranking 201 out of 4220 in its category [2] Fund Management - The fund manager of Anxin Medical Health Stock A is Chi Chenshen, who has been in the position for 4 years and 276 days, managing a total fund size of 946 million CNY [3] - During his tenure, the best fund return was 56.95%, while the worst return was 53.28% [3]

Core Viewpoint - Huakang Clean achieved a significant increase in stock price and trading volume, indicating strong market interest and potential growth in the medical purification system sector [1][2]. Group 1: Financial Performance - For the first half of 2025, Huakang Clean reported revenue of 835 million yuan, representing a year-on-year growth of 50.73% [2]. - The net profit attributable to the parent company reached 18.68 million yuan, showing a substantial increase of 273.48% compared to the previous year [2]. - Cumulative cash dividends since the company's A-share listing amount to 40.02 million yuan, with 29.46 million yuan distributed over the past three years [3]. Group 2: Shareholder and Market Activity - As of September 19, the number of Huakang Clean's shareholders decreased by 2.96% to 10,000, while the average circulating shares per person increased by 3.05% to 7,272 shares [2]. - On September 25, Huakang Clean's financing buy-in amounted to 20.90 million yuan, with a net financing purchase of 1.18 million yuan, indicating strong investor interest [1]. - The total financing and securities balance reached 62.02 million yuan, accounting for 1.67% of the circulating market value, which is above the 90th percentile of the past year [1]. Group 3: Business Overview - Huakang Clean, established on November 12, 2008, specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1]. - The revenue composition of Huakang Clean includes 85.24% from purification system integration, 8.53% from medical consumables, 3.74% from medical equipment sales, and 1.88% from operation services [1]. Group 4: Institutional Holdings - As of June 30, 2025, notable institutional shareholders include Anxin Medical Health Stock A, which is the fifth largest shareholder with 652,800 shares, and Nuoan Multi-Strategy Mixed A, the tenth largest shareholder with 429,900 shares, both being new entrants [3].

Core Viewpoint - The stock of Huakang Clean has experienced fluctuations, with a year-to-date increase of 60.86% but a recent decline in the last five and twenty trading days [1][2]. Company Overview - Huakang Clean is based in Wuhan, Hubei Province, and was established on November 12, 2008, with its listing date on January 28, 2022. The company specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1]. - The revenue composition of Huakang Clean includes: 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, 1.88% from operation services, and 0.61% from other sources [1]. Financial Performance - For the first half of 2025, Huakang Clean achieved an operating income of 835 million yuan, representing a year-on-year growth of 50.73%. The net profit attributable to the parent company was 18.68 million yuan, showing a significant increase of 273.48% [2]. - Since its A-share listing, Huakang Clean has distributed a total of 40.02 million yuan in dividends, with 29.46 million yuan distributed over the past three years [3]. Shareholder Information - As of September 10, 2023, Huakang Clean had 10,300 shareholders, a decrease of 8.37% from the previous period. The average number of circulating shares per person increased by 9.14% to 7,056 shares [2]. - Notable institutional holdings include Anxin Medical Health Stock A as the fifth largest shareholder with 652,800 shares, and Nuoan Multi-Strategy Mixed A as the tenth largest shareholder with 429,900 shares, both being new shareholders [3].

Core Viewpoint - Huakang Clean's stock experienced a decline of 1.07% on September 15, with a trading volume of 129 million yuan, indicating a potential concern in market sentiment towards the company [1]. Financing and Trading Data - On September 15, Huakang Clean had a financing buy-in amount of 8.33 million yuan and a financing repayment of 10.36 million yuan, resulting in a net financing outflow of 2.03 million yuan [1]. - As of September 15, the total financing and securities lending balance for Huakang Clean was 59.11 million yuan, which represents 1.66% of its market capitalization and is above the 80th percentile of the past year, indicating a high level of financing activity [1]. - There were no shares sold or repaid in the securities lending market on September 15, with a securities lending balance of 0, which is above the 70th percentile of the past year, suggesting a lack of short-selling activity [1]. Company Overview - Huakang Clean, established on November 12, 2008, and listed on January 28, 2022, is located in Wuhan, Hubei Province. The company specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1]. - The revenue composition of Huakang Clean includes 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, 1.88% from operation and maintenance services, and 0.61% from other sources [1]. Financial Performance - For the first half of 2025, Huakang Clean reported a revenue of 835 million yuan, reflecting a year-on-year growth of 50.73%. The net profit attributable to the parent company was 18.68 million yuan, showing a significant increase of 273.48% compared to the previous year [2]. - Since its A-share listing, Huakang Clean has distributed a total of 40.02 million yuan in dividends, with 29.46 million yuan distributed over the past three years [3]. Shareholder Information - As of September 10, Huakang Clean had 10,300 shareholders, a decrease of 8.37% from the previous period, while the average number of circulating shares per shareholder increased by 9.14% to 7,056 shares [2]. - Notable institutional holdings include Anxin Medical Health Stock A as the fifth largest circulating shareholder with 652,800 shares, and Nuoan Multi-Strategy Mixed A as the tenth largest with 429,900 shares, both being new shareholders [3].